A

Amalgent Therapeutics

2 employees

Amalgent Therapeutics is developing combination drugs that dramatically reduce the doses required for effective analgesia.

Basic info

Industry

pharmaceutical manufacturing

Sectors

Biotechnology
Health Care
Therapeutics
Medical
Pharmaceutical

Date founded

2020

Funding rounds raised

Total raised

$250K

from 1 investors over 1 rounds

A

Amalgent Therapeutics raised $250K on February 17, 2023

Investors: North Carolina Biotechnology Center (NCBiotech)

FAQ